David Brenner, M.D. a distinguished physician-scientist, is Vice Chancellor for Health Sciences and Dean of the school of Medicine at the University of California, San Diego, since February 1, 2007. In this role, Dr. Brenner leads the UC San Diego School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD Medical Center and UCSD Medical Group. He was recruited to UC San Diego from the Columbia University Medical Center College of Physicians and Surgeons, where from 2003-2007 he was Samuel Bard Professor and Chair of the Department of Medicine, a Member of the Herbert Irving Comprehensive Cancer Center, a Member of the Columbia University Institute of Nutrition, and Physician-in-Chief of New York Presbyterian Hospital/Columbia.
He earned his M.D. from the Yale University School of Medicine. After completing his residency at Yale-New Haven Medical Center, he served as a research associate in the Genetics and Biochemistry Branch of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases of the National Institutes of Health. Dr. Brenner first joined UC San Diego in 1985 as a Gastroenterology Fellow, later joining the medical school faculty, and serving as a physician at the Veterans Affairs San Diego Healthcare System. In 1993 he became Professor and Chief of the Division of Digestive Diseases and Nutrition at the University of North Carolina at Chapel Hill. Dr. Brenner is a leader in the field of gastroenterolocial research, specializing in diseases of the liver. For five years he was Editor-in-Chief of Gastroenterology, the premier journal in the field. The overall theme of his research has been the translation of basic molecular biological principles to the molecular pathophysiology of liver diseases. Over his 15 years as an independent investigator, Dr. Brenner's research has developed into three general areas: the molecular defect in protoporphyria, intracellular signaling in hepatic proliferation and apoptosis, and hepatic fibrosis.